Application | Comment | Organism |
---|---|---|
medicine | great interest in inhibitors as potential therapeutic agents for the treatment of diseases involving aberrant cell proliferation | Mus musculus |
medicine | great interest in inhibitors as potential therapeutic agents for the treatment of diseases involving aberrant cell proliferation | Homo sapiens |
medicine | great interest in inhibitors as potential therapeutic agents for the treatment of diseases involving aberrant cell proliferation | Rattus norvegicus |
Cloned (Comment) | Organism |
---|---|
expressed in Escherichia coli XL-1 Blue, histidine tagged | Mus musculus |
expressed in Escherichia coli XL-1 Blue, histidine tagged | Homo sapiens |
expressed in Escherichia coli XL-1 Blue, histidine tagged | Rattus norvegicus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
A77 1726 | malononitrilamide, 50% inhibition at 18-773 nM | Homo sapiens | |
A77 1726 | malononitrilamide, 50% inhibition at 18-773 nM | Mus musculus | |
A77 1726 | malononitrilamide, 50% inhibition at 18-773 nM | Rattus norvegicus | |
brequinar sodium | 50% inhibition at 6-127 nM | Homo sapiens | |
brequinar sodium | 50% inhibition at 6-127 nM | Mus musculus | |
brequinar sodium | 50% inhibition at 6-127 nM | Rattus norvegicus | |
MNA 279 | malononitrilamide, 50% inhibition at 22-715 nM | Homo sapiens | |
MNA 279 | malononitrilamide, 50% inhibition at 22-715 nM | Mus musculus | |
MNA 279 | malononitrilamide, 50% inhibition at 22-715 nM | Rattus norvegicus | |
MNA 715 | malononitrilamide, 50% inhibition at 41-109 nM | Homo sapiens | |
MNA 715 | malononitrilamide, 50% inhibition at 41-109 nM | Mus musculus | |
MNA 715 | malononitrilamide, 50% inhibition at 41-109 nM | Rattus norvegicus | |
redoxal | 50% inhibition at 45-88 nM | Homo sapiens | |
redoxal | 50% inhibition at 45-88 nM | Mus musculus | |
redoxal | 50% inhibition at 45-88 nM | Rattus norvegicus |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.007 | - |
ubiquinone | - |
Rattus norvegicus | |
0.01 | - |
S-dihydroorotate | - |
Homo sapiens | |
0.011 | - |
S-dihydroorotate | - |
Rattus norvegicus | |
0.014 | - |
ubiquinone | - |
Homo sapiens | |
0.026 | - |
S-dihydroorotate | - |
Mus musculus | |
0.062 | - |
ubiquinone | - |
Mus musculus |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
mitochondrion | inner membrane | Mus musculus | 5739 | - |
mitochondrion | inner membrane | Homo sapiens | 5739 | - |
mitochondrion | inner membrane | Rattus norvegicus | 5739 | - |
mitochondrion | integral protein | Homo sapiens | 5739 | - |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
43000 | - |
x * 43000, SDS-PAGE | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
(S)-dihydroorotate + ubiquinone | Mus musculus | fourth enzyme in pyrimidine synthesis | orotate + ubiquinol | - |
? | |
(S)-dihydroorotate + ubiquinone | Homo sapiens | fourth enzyme in pyrimidine synthesis | orotate + ubiquinol | - |
? | |
(S)-dihydroorotate + ubiquinone | Rattus norvegicus | fourth enzyme in pyrimidine synthesis | orotate + ubiquinol | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Mus musculus | - |
- |
- |
Rattus norvegicus | - |
- |
- |
Purification (Comment) | Organism |
---|---|
Ni2+/nitrilotriacetate column | Mus musculus |
Ni2+/nitrilotriacetate column | Homo sapiens |
Ni2+/nitrilotriacetate column | Rattus norvegicus |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
101 | - |
- |
Mus musculus |
107 | - |
- |
Homo sapiens |
125 | - |
- |
Rattus norvegicus |
Storage Stability | Organism |
---|---|
great inactivation by repeated thawing and freezing | Mus musculus |
great inactivation by repeated thawing and freezing | Homo sapiens |
great inactivation by repeated thawing and freezing | Rattus norvegicus |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
(S)-dihydroorotate + ubiquinone | - |
Mus musculus | orotate + ubiquinol | - |
? | |
(S)-dihydroorotate + ubiquinone | - |
Homo sapiens | orotate + ubiquinol | - |
? | |
(S)-dihydroorotate + ubiquinone | - |
Rattus norvegicus | orotate + ubiquinol | - |
? | |
(S)-dihydroorotate + ubiquinone | fourth enzyme in pyrimidine synthesis | Mus musculus | orotate + ubiquinol | - |
? | |
(S)-dihydroorotate + ubiquinone | fourth enzyme in pyrimidine synthesis | Homo sapiens | orotate + ubiquinol | - |
? | |
(S)-dihydroorotate + ubiquinone | fourth enzyme in pyrimidine synthesis | Rattus norvegicus | orotate + ubiquinol | - |
? |
Subunits | Comment | Organism |
---|---|---|
? | - |
Rattus norvegicus |
? | x * 43000, SDS-PAGE | Homo sapiens |
Synonyms | Comment | Organism |
---|---|---|
DHODH | - |
Mus musculus |
DHODH | - |
Homo sapiens |
DHODH | - |
Rattus norvegicus |
Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
71 | - |
S-dihydroorotate | - |
Mus musculus | |
75 | - |
S-dihydroorotate | - |
Homo sapiens | |
95 | - |
S-dihydroorotate | - |
Rattus norvegicus |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
8 | - |
- |
Homo sapiens |
8 | - |
- |
Rattus norvegicus |
8 | 8.1 | - |
Mus musculus |
8 | 8.1 | - |
Homo sapiens |
8 | 8.1 | - |
Rattus norvegicus |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
additional information | flavoenzyme, 0.6-1.2 mol flavin per mol protein | Mus musculus | |
additional information | flavoenzyme, 0.6-1.2 mol flavin per mol protein | Homo sapiens | |
additional information | flavoenzyme, 0.6-1.2 mol flavin per mol protein | Rattus norvegicus |